CGRP-Targeted Therapies: Contraindications, Safety, and Comparative Efficacy
Reviews when rimegepant and anti-CGRP monoclonal antibodies are appropriate or inappropriate, and compares newer migraine agents with triptans for efficacy and safety.
Duration: 00:02:39
Play / View